期刊文献+

核转录因子κB及其抑制因子研究 被引量:14

Nuclear Transcription Factor κB and Its Inhibitory Factors
下载PDF
导出
摘要 核转录因子κB(NFκB)是一类具有多向调节作用的转录调控因子,且在多个基因的转录及表达过程中发挥重要作用,与炎性相关疾病、肿瘤、疼痛等相关疾病相关。核转录因子抑制蛋白(IκB)主要由核转录因子κB抑制因子(NFκBIA)基因编码,参与调节NFκB信号通路,抑制NFκB功能,其同样与多种炎症性疾病、自身免疫性疾病及肿瘤的易感性有关。近年来,NFκB及其抑制因子在炎症、免疫及肿瘤等方面的影响一直广受关注。此外,NFκB信号通路与疼痛的调节也关系密切,但具体作用机制尚需进一步研究证实。本文主要对NFκB和IκB的结构、分布及表达情况,以及NFκB及NFκBIA基因在炎性疾病、肿瘤和慢性疼痛等多种疾病中的研究进展进行综述,旨在提高临床对其的认识。 Nuclear factor kappa-B(NFκB)is a multifaceted transcriptional regulator that plays an important role in the transcription and expression of multiple genes and is associated with inflammatory diseases,tumors,pain and other diseases.Nuclear transcription factor inhibitor protein(IκB),which is encoded by the Nuclear factor kappa-b inhibitor alpha(NFκBIA)gene,is involved in the regulation of the NFκB signaling pathway and the inhibition of NFκB function.It is also associated with a variety of inflammatory,autoimmune,and tumor susceptibility.The role of NFκB and its suppressor(NFκBIA)in inflammation,immunity,and tumor formation has received considerable attention in recent years.The NFκB signaling pathway is also closely related to pain regulation,but further studies are needed to confirm the specific mechanism.The structure,distribution and expression of NFκB and IκB were introduced and the research progress of NFκB and NFκBIA genes in inflammatory diseases,tumors and chronic pain are reviewed,aiming to improve clinical understanding of them.
作者 石勤业 郭剑 徐建红 SHI Qin-ye;GUO Jian;XU Jian-hong(Department of Anesthesiology,the Fourth Affiliated Hospital of Zhejiang University School of Medicine,Yiwu 322000,Zhejiang,China)
出处 《医学信息》 2020年第22期45-47,54,共4页 Journal of Medical Information
基金 金华市科技局项目(编号:2018-4-144) 义乌市科技局项目(编号:18-3-38)。
关键词 核转录因子ΚB 核转录因子κB抑制因子 炎性 肿瘤 Nuclear factorκappa-B Nuclear transcription factorκappa B inhibitor Inflammation Tumor
  • 相关文献

参考文献4

二级参考文献124

  • 1冯智英,邹静,华驾略,李颖,季伟华,沈沸,李焰生.国际头痛疾患分类第3版(试用版)-原发性头痛部分解读[J].神经病学与神经康复学杂志,2013,10(2):121-140. 被引量:81
  • 2Sasaki Y, Calado DP, Derudder E, et al. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells. Proe NatI Acad Sci USA 2008; 105:10883-10888.
  • 3Vallabhapurapu S, Matsuzawa A, Zhang W, et al. Nonredun dant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immuno12008; 9:1364- 1370.
  • 4Vince JE, Wong WW, Khan N, et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007; 131:682,693.
  • 5Zarnegar B J, Wang Y, Mahoney D J, et al. Noncanonical NF- kappaB activation requires coordinated assembly of a regulatory complex of the adaptors eIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immuno12008; 9:1371-1378.
  • 6Xie P, Stunz LL, Larison KD, Yang B, Bishop GA. Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 2007; 27:253-267.
  • 7Gardam S, Sierro F, Basten A, Mackay F, Brink R. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor, lmmunity 2008; 28:391-401.
  • 8Annunziata CM, Davis RE, Demchenko Y, et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 2007; 12:115-130.
  • 9Keats J J, Fonseca R, Chesi M, et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 2007; 12:131-144.
  • 10Hostager BS, Haxhinasto SA, Rowland SL, Bishop GA. Tu mor necrosis factor receptor-associated factor 2 (TRAF2) deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. JBiol Chem 2003; 278:45382-45390.

共引文献118

同被引文献154

引证文献14

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部